Cite

HARVARD Citation

    Jajosky, A. et al. (2021). Clinical Utility of Targeted Next-Generation Sequencing in the Evaluation of Low-Grade Lymphoproliferative Disorders. American journal of clinical pathology. 156 (3), pp. 433-444. [Online]. 
  
Back to record